The amikacin research program: a stepwise approach to validate dosing regimens in neonates-Reference-Cited by-同舟云学术

The amikacin research program: a stepwise approach to validate dosing regimens in neonates

Published:2016-09-21 Issue:2 Volume:13 Page:157-166
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Smits Anne¹²,Kulo Aida³,van den Anker John⁴⁵⁶⁷,Allegaert Karel⁴⁸

Affiliation:

1. Neonatal Intensive Care Unit, VU Medical Center, Amsterdam, The Netherlands

2. Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium

3. Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia Herzegovina

4. Intensive Care and Department of Surgery, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands

5. Department of Paediatric Pharmacology, University Children’s Hospital Basel, Basel, Switzerland

6. Division of Pediatric Clinical Pharmacology, Children’s National Medical Center, Washington, DC, USA

7. Departments of Pediatrics, Integrative Systems Biology, Pharmacology & Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA

8. Department of Development and Regeneration, KU Leuven, Leuven, Belgium

Funder

JoinEU-SEE

Eraweb

Fund for Scientific Research, Flanders

Science and Technology in Flanders (IWT) through the SAFEPEDRUG

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2017.1234606

Reference67 articles.

1. High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination

2. Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey

3. The role of population PK–PD modelling in paediatric clinical research

4. Aminoglycoside toxicity in neonates: something to worry about?

5. Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacology of antiinfective drugs;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Grading the level of evidence of neonatal pharmacotherapy: midazolam and phenobarbital as examples;Pediatric Research;2023-09-26

3. Drug Dosing in Pediatrics: Possible Approaches;Current Pediatrics;2023-08-25

4. Population pharmacokinetics of amikacin in suspected cases of neonatal sepsis;British Journal of Clinical Pharmacology;2023-03-18

5. Pharmacokinetics of drugs: newborn perspective;Pediatric Medicine;2023-01